Elham Heidari, Pharm.D., M.Sc.

Elham Heidari

Entry into the Program: Fall 2018

Pronouns: She/Her

Advising Professor(s): Dr. Carolyn Brown

Education

  • M.Sc. in pharmacy administration, Duquesne University
  • Pharm.D. Mashhad University of Medical Sciences

Research Interests

  • Health Disparities/ Health Equity, Patient-Reported Outcomes, Pharmacoepidemiology, Real World Data & Information Systems, Social Determinants of Health

Publications

  • Heidari, E., Zalmai, R., Richards, K., Sakthisivabalan, L., & Brown, C. (2023). Z-code documentation to identify social determinants of health among Medicaid beneficiaries. Research in Social and Administrative Pharmacy, 19(1), 180-183.
  • Brown, C., Morlock, A., Blakolmer, K., Heidari, E., & Morlock, R. (2022). COVID-19 vaccination and race–A nationwide survey of vaccination status, intentions, and trust in the US general population. Journal of Managed Care & Specialty Pharmacy, 28(12), 1429-1438.
  • Heidari, E., Brown, C., Johnsrud, M., Mastrangelo, V., Spears, A., Parikh, M., & Campbell, P. J. (2022). Procurement and use of social determinants of health data among key health care stakeholders. Journal of managed care & specialty pharmacy, 28(5), 538–543. 
  • Heidari, E., Rao, D., Pfalzgraf, A. R., Lobo, C., & Giannetti, V. (2022). An Explorative Study of Common Themes of Patient Experiences With Migraine. The Primary Care Companion for CNS Disorders, 24(2), 39985
  • Donovan, E. E., Brown, L. E., Lindstadt, C., Table, B., Heidari, E., Coolidge, A. & Rush, S. (2021). The 12 fundamentals of highly effective communicators: Teaching theory-based professional communication to pharmacy students. Journal of Communication Pedagogy, 4, 21-37
  • Sharifi, F., Khajavi, A., Varmaghani, M., Mehdipour, P., Heidari E, Fakhrzadeh, H., Farzadfar, F., Khoshnevisan, K., Larijani, B. (2021). “Inequality in Prescribing Anti-dementia Medications in Iran: Evidence from Social Security Insurance Claim Data.” Journal of Pharmacoeconomics and Pharmaceutical Management, 7(1/2), 44-52.
  • Varmaghan M, Heidari E, Reiner Ž, Sahebkar A. (2020). At a glance: economic impact of industry-sponsored clinical trials of pharmaceutical products. Journal of Medical Economics, 23(10), 1193-1195.
  • Mansouri M, Sharifi F, Heidari E, Yaghubi H, Keshtkar A, Moghadas Tabrizi Y, Arzaghi M, and Varmaghani M. (2020) “Prevalence of ever self-reported asthma and associated factors among university students in Iran: A population-based study.” International Journal of Preventive Medicine, 11.
  • Covvey, J. R., Kamal, K. M., Gorse, E. E., Mehta, Z., Dhumal, T., Heidari, E., & Zacker, C. (2019). Barriers and facilitators to shared decision-making in oncology: a systematic review of the literature. Supportive Care in Cancer, 27(5), 1613-1637.
  • Varmaghani, M., Dehghani, M., Heidari, E., Sharifi, F., Moghaddam, S. S., & Farzadfar, F. (2019). Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis. Eastern Mediterranean Health Journal, 25(1), 47-57.
  • Taheri, S., Heidari, E., Aivazi, M. A., Shams-Beyranvand, M., & Varmaghani, M. (2018). Cost-effectiveness analysis of Ivabradine in treatment of patients with heart failure in Iran. International Journal of Technology Assessment in Health Care, 34(6), 576-583.
  • Heidari, E., Varmaghani, M., & Abdollahiasl, A. (2019). Availability, pricing, and affordability of selected medicines for noncommunicable diseases. Eastern Mediterranean Health Journal, 25(7), 473-480.
  • Varmaghani, M., Kebriaeezadeh, A., Sharifi, F., Sheidaei, A., Rashidian, A., Moradi‐Lakeh, M., Naghshin, R., Moin, M., Mehdipour, P., Heidari, E. and Gohari, K., (2018). Death‐specific rate due to asthma and chronic obstructive pulmonary disease in Iran. The clinical respiratory journal, 12(6), 2075-2083.
  • Heidari, E., Eslami, S., Abolhassani, F., Sharifi, V., Taherzadeh, Z., & Daneshvar, T. (2017). Association between physicians’ adherence to a pharmacotherapy guideline and continuity of care for patients with depression and/or anxiety disorder. Archives of Iranian Medicine, 20(5), 308.
  • Varmaghani, M., Hashemi-Meshkini, A., Abdollahiasl, A., Heidari, E., Zekri, H. S., Yaghoubifard, S., & Dorkoosh, F. (2016). An overview to pharmaceutical financing in Iran. Journal of Pharmacoeconomics and Pharmaceutical Management, 2(1/2), 45-49.

Presentations

  • Heidari, E, Lindstadt, C, Coolidge, D, Omran, S, Donovan, E & Rush, S. Features of Empathy in Pharmacy Students’ Self-Assessments: Thematic Analysis and Association with OSCE Grades. Oral presentation at Academy of Communication in Healthcare virtual symposium, June 2020.
  • Heidari, E, Giannetti, V, Kamal, K & Covvey, JR.  Data-driven impact of depression, anxiety, and antidepressant treatment on clinical outcomes for type 2 diabetes mellitus, Drug Information Association (DIA) annual meeting, San Diego, June 2019.
  • Heidari E, Watson C, Thirumalai, D, Barlev, A, Jones E, Bogdanovich, S, & Kresa-Reahl, K. Work Productivity Impairment among Individuals with Progressive Multiple Sclerosis, ISPOR 2023, Boston, MA.
  • Heidari E, Watson, C, Thirumalai, D, Barlev, A, Jones, E, Bogdanovich, S & Kresa-Reahl, K. Work Productivity Impairment by Type of Worker in Active and Nonactive Progressive Multiple Sclerosis, ISPOR 2023, Boston, MA.
  • Heidari E, Watson, C, Thirumalai, D, Barlev, A, Jones, E, Bogdanovich, S & Kresa-Reahl, K. Physical and Psychological Impact in Individuals With Active and Nonactive Primary and Secondary Progressive Multiple Sclerosis in the United States, ACTRIMS 2023, San Diego, CA.
  • Heidari E, Zalmai, R, Brown, C & Baffoe, J. The influence of patient-provider communication on colorectal cancer screening uptake: analysis of a national survey in the United States. AMCP 2023, San Antonio, TX. Presented at research excellence day in College of Pharmacy, UT Austin.
  • Heidari, E, Brown, C, Morlock, R, Morlock, A & Blakolmer, K. Children's COVID-19 Vaccination and Race - a Nationwide Survey of Children's Vaccination Status and Trust in the U.S. General Population. ISPOR annual meeting, May 2022.
  • Heidari, E, Zalmai, R, Brown, C & Richards, K.  Z-Code Documentation to Identify Social Determinants of Health Among Medicaid Beneficiaries in Texas. ISPOR annual meeting, May 2022; Presented at research excellence day in College of Pharmacy, UT Austin.
  • Heidari, E, Burcu, M, Ghate, S & Shui, I. Real-world algorithms in defining castration resistant prostate cancer in retrospective observational studies, ISPE’s 37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 37), August 2021.
  • Heidari, E, Brown, C, Johnsrud, M, Campbell, P, Mastrangelo, V, Parikh, M & Spears, A. Procurement and Use of Social Determinants of Health Data Among Key Healthcare Stakeholders, Academy Health 2021 Virtual Annual Research Meeting (ARM), June 2021 and presented at research excellence day in College of Pharmacy, UT Austin. Healthier Texas Summit 2021
  • Heidari, E, Lindstadt, C, Coolidge, D, Omran, S, Donovan, E & Rush, S. Features of Empathy in Pharmacy Students’ Self-Assessments: A thematic Analysis. Virtually presented at school of pharmacy research day, April 2020/ Virtual Interprofessional Health Showcase, May 2020, UT Austin, TX.
  • Heidari, E, Okoh, C, Vohra, Y & Brown, C. Role of Social Determinants of Health (SDoH) in health plans’ decision making: A review of the literature. Received acceptance from AMCP annual meeting, cancelled due to COVID-19 outbreak. On-line abstract published, April 2020.
  • Heidari, E, Giannetti, V, Kamal, K, & Covvey, JR. Impact of antidepressant treatment dose on clinical outcomes of type 2 diabetes mellitus in primary care patients in western Pennsylvania, ISPOR annual meeting, May 2019, New Orleans, LA.
  • Lindstadt, C, Wash, A, Heidari, E, Table, B, Brown, L, Donovan, E & Rush, S. Applied Communication Skills Training for Pharmacy Students: Practicing an Interprofessional Voicemail, May 2019, Center for Health IPE Interprofessional Health Showcase, UT Austin, TX.
  • Taheri, S, Varmaghani, M, Heidari, E, Yousefi, N, & Peiravian, F. PIH7-Long-Acting recombinant FSH versus recombinant FSH as assisted reproduction techniques in the management of infertility: a systematic review and meta-analysis. Value in Health, 21, S214-S215. ISPOR 2018 Barcelona.
  • Heidari, E, Giannetti, V, Kamal, K, & Covvey, JR. The influence of depression and anxiety upon clinical outcomes for type II diabetes. ACCP virtual symposium 2018.
  • Heidari, E, Kamal, KM, Giannetti, V & Covvey, JR. The Impact of Antidepressant Medications on Clinical Outcomes of Patients with Type 2 Diabetes: A Systematic Review Value in Health 21, S70. ISPOR Baltimore 2018.
  • Rao, D, Heidari, E, Giannetti, V, Pfalzgraf, A & Lobo, C. Patient Experiences: A qualitative approach to patient experiences in migraine. INNOVATIONS in pharmacy: SAPH, MIDWEST 2018.
  • Rao, D, Heidari, E, Kamal, KM & Dashputre, AA. Cost-Effectiveness of Daclizumab Versus Interferon Beta-1A in the Treatment of Patients with Relapsing-Remitting Multiple Sclerosis in the United States. Value in Health 21, S206. ISPOR Baltimore 2018.
  • Vadagam, P, Heidari, E, Cauly, B & Kamal, KH. Patient preference and satisfaction with oral oncolytics: a review of available instruments and their psychometric performance. ISPOR Annual International Meeting; Boston, MA. May 2017.
  • Heidari, E & Abdollahiasl, A. Availability, price, and affordability of selected medicines for non-communicable diseases in Iran: a comparison of 2007 and 2014 reports. ISPOR Annual International Meeting; Boston, MA. May 2017.
  • Heidari, E & Abolhassani, F. Prevalence of depression and anxiety among women referring to a mental health collaborative care center in Tehran. Iranian International Conference on Women’s Health, Shiraz, Iran. May 2016. First Outstanding Paper Award

Internship/Graduate Research Assistantship

  • Graduate Associate – Global Value, Access and Outcomes Department, May-August 2022, Atara Biotherapeutics 
  • Graduate Research Intern – Payer Outcome Department, June- August 2021, Amgen 
  • Graduate Intern – Health Economics and Outcomes Research (HEOR), February-May 2021, Precision 
  • Pharmacoepidemiology Graduate Intern – Center for Observational and Real-World Evidence (Core), May-August 2020, Merck

Contact Information

Why UTCOP HOD?

  • I chose UTCOP HOD because of the rigor of the program.

What do you enjoy outside of school?

  • I like working out and cooking new recipes.